Palo Alto, CA and Acton, MA —Target Discovery, Inc., a discovery biology company, today announced that it has entered into a product technology collaboration with Groton Biosystems, LLC, a subsidiary of Groton Technology, Inc. Target Discovery and Groton Biosystems are working together on the development and market introduction of new and innovative capillary electrophoresis analysis systems, incorporating Target Discovery’s technology and products into Groton Biosystems’s leading-edge on-line and laboratory process monitoring solutions for protein production applications. Initial products resulting from this collaboration have entered the market, although details and financial terms were not disclosed.

“This agreement between Target Discovery and Groton Biosystems will bring products to market that will help researchers attain state-of-the-art efficiency in production process monitoring,” said Jeffrey N. Peterson, chief executive officer of Target Discovery. “The precise and rapid analysis of complex protein mixtures is of ever-increasing importance as pharmaceutical and biotechnology companies are moving rapidly from development to manufacturing of biological products. These firms require top-notch analytical and separation technologies to meet stringent quality control requirements for their manufacturing processes. The novel technologies resulting from this collaboration provide an important advance into a new era in productivity for life science research.”

“We are impressed with Target Discovery’s broad expertise in capillary electrophoresis and other technologies. Tapping into this expertise has allowed us to strengthen and differentiate our product offerings, contributing towards our goal of providing the highest capabilities and value in on-line and laboratory process monitoring solutions for our protein production clients,” said Bill Dinardo, chief executive officer of Groton Biosystems. “We believe that incorporating Target Discovery’s products and technologies into our offerings is a key contributor to providing real-time production monitoring that maximizes protein yield, creates lot-to-lot consistency, and builds cost-effective manufacturing processes.”

About Target Discovery, Inc.
Target Discovery is a discovery biology company that seeks to alleviate critical bottlenecks imposed by current technologies upon drug development and life science research. The company is developing new platform technologies for the elucidation of high quality biological data and for the conversion of that information into a confirmed understanding of biological pathways. Pathway understanding enables new efficiencies in the identification, selection and development of optimal disease targets, biomarkers and drug candidates. Target Discovery is introducing selected technology platforms in reagent and software products and engages in discovery collaborations. The company is based in Palo Alto, California. More information is available at www.targetdiscovery.com.

About Groton Biosystems, LLC.
Groton Biosystems is a pioneer in providing protein production companies with leading edge on-line and laboratory process monitoring solutions. The Groton Biosystems team is focused specifically on the biotech industry. As a result the company offers the most cost effective solutions for monitoring the entire research and manufacturing process. Groton Biosystems maintains a focused commitment to the growing needs of the recombinant protein market and is dedicated exclusively to the development, manufacture, support and sale of products for this market. The latest products are designed specifically for companies whose process includes a bioreactor or fermenter for recombinant protein production. Groton Biosystems is headquartered in Acton, Massachusetts, 25 miles northwest of Boston, in the heart of Massachusetts' Biotechnology sector. More information is available at www.grotonbiosystems.com.